Lv1
90 积分 2023-01-10 加入
The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis
11天前
已完结
Sitagliptin in type 2 diabetes mellitus: Efficacy after five years of therapy
18天前
已完结
Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial
20天前
已完结
Patient Compliance and Persistence with Anti-Hyperglycemic Therapy: Evaluation of a Population of Type 2 Diabetic Patients
26天前
已完结
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023–2024
27天前
已完结
Glycemic Improvement with a Fixed‐dose combination of DPP ‐4 inhibitor + metformin in patients with Type 2 diabetes ( GIFT study)
1个月前
已完结
Fixed-Dose and Fixed-Ratio Combination Therapies in Type 2 Diabetes
1个月前
已完结
Delays in anti‐hyperglycaemic therapy initiation and intensification are associated with cardiovascular events, hospitalizations for heart failure and all‐cause mortality
1个月前
已完结
Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy
1个月前
已完结
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care
1个月前
已完结
皖公网安备34019202002308
